市场调查报告书
商品编码
1471244
增溶添加剂市场:依产品类型、应用分类 - 2024-2030 年全球预测Solubility Enhancement Excipients Market by Product (Particle Size Reduction, Solid Dispersion), Type (Lipid, Polymer, Surfactant), Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
增溶剂市场规模预估2023年为36.3亿美元,预估2024年将达38.2亿美元,2030年将达53.3亿美元,复合年增长率预估为5.62%。
增溶添加剂是一类特定的药物成分,主要用于药品製造过程中,以增加难溶化合物的溶解度。它透过促进药物在体内溶出,在提高生物有效性和增强治疗效果方面发挥重要作用。由于慢性病的增加以及药物发现和开发,製药业对增强溶解度添加剂的需求正在加速成长。然而,原料成本的波动和严格的法规可能会对最终用途领域中增溶剂的使用产生负面影响。此外,奈米技术的普及、生物基赋形剂的加入以及多功能赋形剂的开发预计将为增溶添加剂领域的发展提供巨大的潜力。
主要市场统计 | |
---|---|
基准年[2023] | 36.3亿美元 |
预计年份 [2024] | 38.2亿美元 |
预测年份 [2030] | 53.3亿美元 |
复合年增长率(%) | 5.62% |
消费者喜欢减小粒径,因为它可以提高产品的载药效率
粒径减小 (PSR) 涉及减小药物或赋形剂的粒径以增加表面积和溶解度。此製程具有相当大的优势,包括提高载药效率、优异的均匀性和提高溶离度,特别是对于水溶性差的药物。固体分散体是一种将疏水性药物有效封装在水溶性载体基质中的策略。当配製经减小粒径无法达到所需溶解度的药物时,优选固态分散体。儘管粒径减小相对简单且成本效益高,但并非对所有类型的药物都有效,尤其是水溶性极低的药物。固体分散体可处理此类难以溶解的药物。它更昂贵,因为它需要更复杂的工艺和先进的技术。
类型:广泛使用界面活性剂作为增溶剂添加剂来开发基于界面活性剂的药物递送系统
由于脂质无毒性、生物分解性以及形成各种包合物结构(例如胶束和脂质体)的能力,脂质通常被用作溶解度增强添加剂。由于聚合物的多功能性和相对较低的生产成本,聚合物对于提高溶解度至关重要。界面活性剂无所不在,因为它们能够稳定水-油界面并降低表面张力,这对于增加溶解度非常重要。脂质因其安全性和生物分解性而受到重视,表面活性剂因其稳定特性而受到重视,聚合物因其经济性和适应性而受到重视。
应用:增溶剂在製药领域的重要角色是促进产品卓越。
医疗保健是医疗系统的第一线,快速反应至关重要。增加溶解度的赋形剂可加速药物在体内的吸收,快速缓解患者的症状。在製药领域,需要增强溶解度的添加剂来增强口服药物的吸收,并优先考虑药物在各种条件下的稳定性、安全性和有效性。医院寻求更快的吸收以立即缓解患者的痛苦,而製药部门则专注于药物的稳定性、安全性和有效性。
区域洞察
在美洲,由于製药工业的成熟、药物配方的创新以及药物製造技术的进步,增溶添加剂市场正在发展。在亚太地区,由于慢性病的增加、研发活动的活性化以及学名药产量的增加,对增溶剂的需求正在显着增长。由于强大的研发基础、新型口服辅料的持续开发以及不断扩大的医疗基础设施,欧洲、中东和非洲 (EMEA) 对增强溶解度的辅料表现出很高的需求。此外,增溶添加剂生产的技术进步以及改善其性能的持续研究预计将扩大增溶添加剂在全球最终用途领域的使用。
FPNV定位矩阵
FPNV定位矩阵对于评估增溶剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对增溶添加剂市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,以获得市场竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.增溶剂市场规模及预测是多少?
2.在增溶添加剂市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.增溶剂市场的技术趋势和法规结构是什么?
4.增溶添加剂市场主要供应商的市场占有率为何?
5. 进入增溶添加剂市场的合适型态和策略手段是什么?
[190 Pages Report] The Solubility Enhancement Excipients Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 3.82 billion in 2024, at a CAGR 5.62% to reach USD 5.33 billion by 2030.
Solubility enhancement excipients are a specific category of pharmaceutical ingredients used primarily in the drug manufacturing process to increase the solubility of poorly soluble drug compounds. They play a critical role in bioavailability enhancement, facilitating the dissolution of drugs into the body and thus increasing their therapeutic effectiveness. The rise in chronic diseases and increase in drug discovery and development are accelerating the need for solubility enhancement excipients from the pharmaceutical industries. However, volatility in raw material cost and stringent regulations may adversely impact the use of solubility enhancement excipients by the end-use sectors. Moreover, the proliferation of nanotechnology, the incorporation of bio-based excipients, and the development of multifunctional excipients are expected to create immense potential for the growth of solubility enhancement excipients worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.63 billion |
Estimated Year [2024] | USD 3.82 billion |
Forecast Year [2030] | USD 5.33 billion |
CAGR (%) | 5.62% |
Product: Consumer preference for particle size reduction as it provides improved drug loading efficiency
Particle size reduction (PSR) involves reducing the particle size of drug substances or excipients to enhance the surface area and solubility. This process offers considerable advantages, such as improved drug loading efficiency, excellent homogeneity, and improved dissolution rate of drugs, particularly for drugs with poor water solubility. Solid dispersion is the strategy for efficiently encapsulating a hydrophobic drug within a water-soluble carrier matrix. It is preferred when dealing with the formulation of drugs that cannot achieve desired solubility levels through particle size reduction. Particle size reduction is comparatively easier and cost-effective, but it is not effective for all types of drugs, especially those with extremely poor water solubility. Solid dispersion handles tough-to-solubilize such medicines. It needs more complex steps and sophisticated technologies, making it more expensive.
Type: Extensive utilization of surfactants as solubility enhancement excipients to develop surfactant-based drug delivery systems
Lipids are often employed as solubility enhancement excipients due to their no toxicity, biodegradability, and capacity to form various inclusion structures like micelles and liposomes. Polymers are vital in solubility enhancement due to their versatility and relatively inexpensive production costs. Surfactants are ubiquitous due to their capacity to stabilize water-oil interfaces and reduce surface tension, which is critical in enhancing solubility. Lipids are appreciated for their safety and biodegradability, surfactants for their stabilizing properties, and polymers for their affordability and adaptability.
Application: Significant role of solubility enhancement excipients in the pharmaceutical field to drive product excellence
Hospitals are the frontline of the healthcare system, where immediate attention is paramount. A solubility enhancement excipient enables faster absorption of the drug into the body, providing quicker relief to the patient. The pharmaceutical sector requires solubility enhancement excipients to increase the absorption of orally taken drugs and prioritize drug stability, safety, and efficacy in different conditions. Hospitals demand faster absorption for immediate patient relief, while the pharmaceutical sector focuses on drug stability, safety, and effectiveness.
Regional Insights
The solubility enhancement excipients market is evolving in the Americas owing to the well-established pharmaceutical industries, innovations in drug formulation, and technological advancements in drug manufacturing. The Asia Pacific is witnessing significant demand for solubility enhancement excipients due to the increasing prevalence of chronic diseases, the surge in research and development activities, and high generic drug production. Europe, Middle East, and Africa (EMEA) represent high demand for solubility enhancement excipients with strong research and development foundations, ongoing development of novel excipients used in oral administration, and expanding healthcare infrastructure. Besides, technological advancements in the manufacturing of solubility enhancement excipients and ongoing research to improve their properties are anticipated to expand the use of solubility enhancement excipients across the end-use sectors globally.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Solubility Enhancement Excipients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Solubility Enhancement Excipients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Solubility Enhancement Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Air Liquide S.A., Ashland Global Holdings Inc., BASF SE, Cargill, Incorporated, Clariant International Ltd., Croda International PLC, DuPont de Nemours Inc., Evonik Industries AG, FMC Corporation, FREUND Corporation, Gattefosse, IMCD Group, JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Merck KGaA, Nippon Soda Co. Ltd., Pharma Excipients International AG, Roquette Freres SA, Shin-Etsu Chemical Co., Ltd., Solvay SA, SPI Pharma Inc., The DOW Chemical Company, and Wacker Chemie AG.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Solubility Enhancement Excipients Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Solubility Enhancement Excipients Market?
3. What are the technology trends and regulatory frameworks in the Solubility Enhancement Excipients Market?
4. What is the market share of the leading vendors in the Solubility Enhancement Excipients Market?
5. Which modes and strategic moves are suitable for entering the Solubility Enhancement Excipients Market?